Status:
COMPLETED
Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
Beijing Municipal Health Commission
Conditions:
Regional Anesthesia
Anesthesia, Local
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Paravertebral block (PVB) has been regarded as effective regimen for pain control after cardiac surgery. As a novel analgesia technique, erector spinae plane block (ESPB) has been reported to provide ...
Detailed Description
Minimally invasive direct coronary artery bypass grafting has recently gained with popularity in treatment of coronary artery disease. Compared with conventional approach, it has advantages of less tr...
Eligibility Criteria
Inclusion
- patients undergoing elective minimally invasive direct coronary artery bypass grafting
Exclusion
- Contraindications to regional anesthesia (coagulopathy, infection of the skin at the site of needle puncture area, et al)
- Morbid obesity (body mass index \> 35 kg/m2)
- Allergy to any of the study drugs
- Chronic opioid use or history of opioid abuse.
- Inability to understand pain score
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05320718
Start Date
March 1 2022
End Date
December 30 2023
Last Update
January 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology,Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
2
Peking University Third Hosptial
Beijing, China, 100191